Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cellebrite DI Ltd. - Ordinary Shares (NQ:CLBT)

17.65 +0.39 (+2.26%)
Streaming Delayed Price Updated: 11:33 AM EDT, Sep 18, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Cellebrite DI Ltd. - Ordinary Shares

< Previous 1 2 Next >
Applied Materials To Rally Around 17%? Here Are 10 Top Analyst Forecasts For Friday
 
Via Benzinga
Super League, Terawulf, Cellebrite Dominate Stocktwits Retail Chatter Among Tech Stocks: Find Out Why
Via Stocktwits
Cellebrite Reports 21 Percent ARR Growth
Via The Motley Fool
Cellebrite Begins Its Next Chapter
Cellebrite experienced solid growth in Q2 2025, exceeding expectations for sales and earnings. Signs of a rebound are encouraging. 
Via The Motley Fool
Cellebrite DI Ltd (NASDAQ:CLBT) Posts Mixed Q2 2025 Earnings Amid Leadership Changes and Strategic Moves
Cellebrite reports mixed Q2 2025 results: revenue slightly misses estimates at $113.3M, while EPS beats at $0.12. New CEO appointed amid leadership changes and strategic acquisitions. Stock dips... 
Via Chartmill
Earnings Scheduled For August 14, 2025
 
Via Benzinga
Is This Stock a Next-Gen Digital Forensics Leader?
Via The Motley Fool
Earnings Scheduled For February 13, 2025
 
Via Benzinga
Earnings Scheduled For February 15, 2024
Companies Reporting Before The Bell • Cognex (NASDAQ:CGNX) is estimated to report quarterly earnings at $0.10 per share on revenue of $188.59 million. 
Via Benzinga
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
The Benzinga Stock Whisper Index looks at five stocks seeing increased attention from readers during the week and a look at what could be causing the increased interest. 
Via Benzinga
Dow Edges Higher; US Crude Oil Inventories Increase
 
Via Benzinga
Topics Stocks
5 Technology Names That Saw Brisk Retail Activity On Stocktwits Last Week
Earnings news has catalyzed frenzied activity in these stocks, and irrespective of the directional moves, sentiment toward them has remained uniformly upbeat. 
Via Stocktwits
The S&P 500 Fights Through Challenging Headlines To Close At New Weekly All-Time Highs
In this video lesson, I review the resilient overall market, stocks on my radar for the short and long-term portfolio, and a new EOD swing trade, for Tuesday's session. Happy trading. Aloha. 
Via Talk Markets
Topics Stocks Stocks / Equities
Cellebrite DI: Q3 Earnings Insights
 
Via Benzinga
What 4 Analyst Ratings Have To Say About Cellebrite DI
 
Via Benzinga
Expert Ratings for Cellebrite DI
 
Via Benzinga
Earnings Scheduled For May 14, 2025
 
Via Benzinga
Preview: Cellebrite DI's Earnings
 
Via Benzinga
Mailbag With Motley Fool Co-Founder Tom Gardner
Today's show is a cut of our members-only podcast, "Stock Advisor Roundtable." 
Via The Motley Fool
H&R Block Posts Upbeat Earnings, Joins Alibaba Group, CI&T And Other Big Stocks Moving Higher On Friday
 
Via Benzinga
CLBT Stock Earnings: Cellebrite DI Beats EPS, Beats Revenue for Q2 2024
CLBT stock results show that Cellebrite DI beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
Will The Nasdaq 100's Relief Rally Hold Or Is A Sharp Decline Inevitable?
Find out how might the rotation of funds into small-cap stocks and the Dow Jones affect the Nasdaq 100. 
Via Talk Markets
Topics Stocks
Recap: Cellebrite DI Q1 Earnings
 
Via Benzinga
FBI Reportedly Used Israel-Based Security Firm's Unreleased Technology To Crack Trump Shooter's Phone
Despite having a license for Cellebrite's software, the FBI's Pittsburgh bureau was unable to bypass the passcode on Crooks' newer Samsung model phone, which runs on Android's operating system. 
Via Benzinga
Topics Government
Why Software Company Cellebrite Shares Are Up Today
Cellebrite DI reported strong Q1 FY24 results with revenue up 26% YoY, ARR at $331.8 million, and EPS beating consensus. Outlook remains positive with expected revenue of $90M-$94M in Q2 and... 
Via Benzinga
CLBT Stock Earnings: Cellebrite DI Beats EPS, Beats Revenue for Q1 2024
CLBT stock results show that Cellebrite DI beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
The 7 Best Stocks Under $10 to Buy in May
While quality matters in the market, these best stocks under $10 to buy gives you some potential diamonds in the rough. 
Via InvestorPlace
Major Compression Regimes In Multiple Markets…
In this week’s Dirty Dozen we cover more recession signals, bullish price action in the main markets, a big set up in the US dollar, a major compression regime in bonds, and more… 
Via Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For July 19, 2023
 
Via Benzinga
7 Tech Stocks to Buy for the Next Decade
While jitters abound, intrepid investors may target these compelling innovators. 
Via InvestorPlace
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.